Light Line Medical today said it entered into a “know-how” license agreement with Mayo Clinic to advance its visible light infection prevention system for off-the-shelf catheters.
The collaboration will focus on the technology in peritoneal dialysis catheters, Foley (urinary) catheters and endotracheal tubes and vascular catheters. It will also focus on finalizing the development of a low-cost, intuitive, effective infection prevention system that uses light generated by an LED laser delivered to an indwelling catheter.
Light Line Medical designed the sterilization technology to prevent catheter-associated infections during peritoneal dialysis. It uses a particular wavelength in the visible light spectrum generated by an LED laser and delivered through a specially treated fiber optic to deliver uniform light down the length of the catheter. The company hopes it will encourage patients to elect and stay on peritoneal dialysis at home instead of in-clinic hemodialysis.
“Infections are the number one reason patients fear peritoneal dialysis. Preventing these infections furthers the mission of the Advancing American Kidney Health Initiative to produce better outcomes for patients and to expand home dialysis options,” CEO Vicki Farrar said in a news release.
The company plans to launch its peritoneal dialysis product in the U.S. in early 2024 with global launches of its dialysis product to follow.
Mayo Clinic said it has a financial interest in the technology and will use any revenue received to support its not-for-profit mission in patient care, education and research.
